MBIA reported Q1 2026 results with a consolidated GAAP net loss of $40 million ($0.80 per share), improved from $62 million loss in Q1 2025, driven by favorable foreign exchange impacts and reduced investment losses. The company's PREPA exposure remains unchanged at $425 million with no progress on negotiations pending litigation resolution. National's gross par outstanding declined $900 million to $21.5 billion with improved leverage ratio. Management indicated no active strategic process updates regarding potential sale, merger, or other alternatives.

The article discusses the upcoming 9th Annual New York CISO & Technology Leadership Summit, which will focus on topics such as navigating the Supercycle of innovation, securing against geopolitical cyber risks, and balancing cost and cybersecurity. The event will feature industry experts, including former U.S. National Coordinator for Security Richard Clarke, who will provide insights on communicating risk and justifying security investments.

Lemonade (LMND) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Equinix (EQIX) delivered FFO and revenue surprises of 3.26% and 0.57%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Oscar Health (OSCR) delivered earnings and revenue surprises of 121.43% and 9.50%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Hippo Holdings (HIPO) delivered earnings and revenue surprises of -4.26% and 25.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

MBIA (MBI) delivered earnings and revenue surprises of -500% and 12.50%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Radian (RDN) delivered earnings and revenue surprises of 15.66% and 2.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 8.89% and 2.43%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Kemper (KMPR) delivered earnings and revenue surprises of 0% and 3.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Amidst the resounding fanfare surrounding the Nasdaq 100’s record-breaking surge, U.S. small-cap stocks have quietly carved out their own moment of glory. Rally Record: The Russell 2000 index, closely monitored through the iShares Russell 2000 ETF (NYSE:IWM), has experienced a remarkable year-end rally, reaching levels not witnessed since August 2022. Consistent Climb: This class of stocks has been riding a six-week winning streak, their longest since December 2020, reflecting a sweeping advance rather than isolated successes. Bullish Breadth: What’s particularly striking is the breadth of this rally, with over 80% of the stocks within the Russell index, accounting for approximately 1,600 companies, trading above their respective 50-day moving averages. This indicates a robust performance across a wide spectrum of small-cap stocks, rather than being limited to a select few. Outperformance vs. Large Caps: After ...Full story available on Benzinga.com

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Friday. The Dow traded up 0.36% to 36,248.73 while the NASDAQ rose 0.48% to 14,409.22. The S&P 500 also rose, gaining, 0.42% to 4,604.73. Check This Out: Insiders Buying Bristol-Myers Squibb And 3 Other Stocks   Leading and Lagging Sectors   Energy shares rose by 0.7% on Friday. In trading on Friday, real estate shares fell by 0.9%.   Top Headline   The total number of active U.S. oil rigs fell by 2 to 503 rigs this week, Baker Hughes Inc reported.   Equities Trading UP   Intensity Therapeutics, Inc. (NASDAQ: INTS) shares shot up 83% to $7.67. Intensity Therapeutics presented INT230-6 data in early-stage breast cancer patients. Shares of MBIA Inc. (NYSE: MBI) got a boost, shooting 77% to $13.05 after the company announced it declared an extraordinary cash dividend on MBIA common stock of $8.00 per share. Torrid Holdings Inc. (NYSE: CURV) shares were also up, gaining 21% to $5.03 after the company reported better-than-expected third-quarter financial results and issued FY23 ...